Amgen Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amgen (AMGN) PT Raised to $180 at UBS Following Solid 2Q
July 26, 2017 8:34 AM EDTUBS raised its price target on Amgen (NASDAQ: AMGN) to $180.00 (from $175.00) while maintaining a Neutral rating. 2Q results were better than expectations with a $145M top-line beat. EPS also beat consensus estimates by $0.18.
UBS increased 2017 Enbrel sales estimates to $5.38B from $5B... More
Amgen (AMGN) PT Raised to $174 at Deutsche Bank
July 26, 2017 6:18 AM EDTDeutsche Bank raised its price target on Amgen (NASDAQ: AMGN) to $174.00 (from $172.00) while maintaining a Hold rating.
Analyst Andrew Peters called the quarter "solid" but said the near term outlook remains challenged.
"While the results beat expectations, we remain cautious on... More
Amgen (AMGN) Tops Q2 EPS by 16c, Lifts FY Guidance
July 25, 2017 4:04 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $3.27, $0.16 better than the analyst estimate of $3.11. Revenue for the quarter came in at $5.81 billion versus the consensus estimate of $5.67 billion.
GUIDANCE:
Amgen sees FY2017 EPS of $12.15-$12.65, versus the consensus of $12.49. Amgen sees... More
